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 INTRODUCTION 
 
HIV virus encodes for several accessory proteins in particular Vif protein that is essential in an early phase of viral infection.  
In 2002, it was demonstrated an interaction between Vif and APOBEC (1), that inhibits APOBEC (cytidine deaminase) function and at the same time 
reduces APOBEC incorporation in the virion. 
Earlier studies suggested that Vif functions in viruses producing cells (permissive and non permissive) but its activity influences early stages of viral 
infection (2). Other studies also revealed that Vif is necessary to maintain productive viral infection (3). 
We have performed several two-hybrid screenings of cDNA libraries (from PBMC, IL-2 stimulated), using Vif1 and Vif2 as baits. In all screenings we have 
identified a specific interaction with Histone 3 variant, H3.3, whereas interactions with histones H2A and H2B, and with other HIV proteins, used as 
controls, were negative. 
CONCLUDING REMARKS 
 
Our results show that Vif interacts specifically with H3.3 and also with H3 (data not shown), which only differs in 2 amino acids. The high levels of homology 
obtained between conserved sequences of Vif1 and Vif2 and histone chaperones indicate that Vif could act as a histone chaperon, specific for histone H3.3 and 
histone H3. 
Although biological relevance of this interaction is still not well defined, if we compare our results with results obtain with others viruses that showed interactions 
between viral proteins and histone chaperones that result in viral replication activation (5), we hypothesize that Vif acts as a histone chaperon itself, playing an 
important role in transcriptional activation, since H3.3 is an epigenetic positive tag for activation of transcription, in chromatin modulation. Inactivation of H3.3 gene 
will clarify the biological meaning of this interaction for HIV replication. 
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Using the two-hybrid system we have 
identified the interacting  domain 
between Vif2 and histone H3.3. 
 
We used different constructs from 
H3.3, Vif1 and Vif2, as well as, a 
conserved motif from Vif2 (named 
OligoVif2) that is localized between 
139 and 158 aa residues. As we can 
observed the domain is localized in 
the COOH terminal of H3.3 histone 
and Vif2 protein. For Vif1 and with the 
constructs that we have used the 
results are not so conclusives. 
HeLa cells were co-transfected with 
HA-Vif1, HA-Vif2, HA-TE and c-myc 
histone H3.3. Immunolocalization 
was performed at 19h pos-
transfection fixeted cells. 
 
HA-TE (a peroximal enzyme), was 
used has negative control for HA tag.  
 
On C, F, I its possible to see merge of 
both tag detections. On panel A and 
D we see that both Vif1 and Vif2 have 
nuclear localization,  same results 
were obtain with suspension cell 
lines, like T cell lines (H9) and 
macrophagic cell lines (U38). 
 
Lentivirus conserved motif  
Vif 2 
22%          ASF1 anti-silencing function 1 like protein  [Cryptosporidium parvum Iowa II] 
44%                      Histone chaperone ASF1, putative [Metarhizium anisopliae ARSEF 23] 
88%                                                             Histone chaperone RTT106 [Yarrowia lipolytica] 
66%                        Global regulator of transcription [Scheffersomyces stipitis CBS 6054] 
 
C 
Vif 1 
Lentivirus conserved motif  
47%  Facilities chromatin transcription comp. subSPT16 [Oryza sativa Japonica ] 
47%                                                              FACT complex subunit SPT16 [Zea mays] 
64%                                                Histone chaperone RTT106 [Yarrowia lipolytica] 
35%                       anti-silencing ASF1-like protein [Cryptosporidium muris RN66] 
47%                               HIRA-interacting protein 3-like [Ailuropoda melanoleuca] 
 
B 
Vif 1 
Lentivirus conserved motif  
 83%                                                         RNA polymerase II-associated protein 1 Human 
66%        Hira protein, histone chaperone Hip1 [Schizosaccharomyces pombe 972h-] 
 100%                                           Anti-silencing protein a-like protein [Leishmania major] 
 83%                                  Anti-silencing function 1A-like [Oryza sativa Japonica Group] 
     66%                                              Nucleosome assembly factor [Micromonas sp. RCC29 
66%                                                                                Histone deacetylase 4; Short=HD4 
        83%         Nucleosome assembly protein 1-like protein 3 [Oryza sativa Indica Group] 
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            1 
HIV-2 Ali   MEEGKRWIVV  PTWRVPGRME  KWHSLVKYLK  YRTKDLEKVC  YVPHHKVGWA  
HIV-1 HxB2  ..NRWQVMI.  WQVDRM-.IR  T.K...HHMY  VSG.ARG-WF  .RH.YESPHP 
 
            51 
HIV-2 Ali   WWTCSRVIFP  LQGKSHLEIQ  AYWNLTPEKG  WLSSYAVRIT  WYTEKFWTDV 
HIV-1 HxB2  RISSEVH.PL  GDARLVITT-  YWGLH.G.RD  .HLGQG.S.E  .RKKRYS.Q. 
 
            101  
HIV-2 Ali   TPDCADSLIH  GTYFSCFTAG  EVRRAIRGEK  SLSCCNYPQA  HKSQVPSLQF  
HIV-1 HxB2  D.EL..Q.Y.  LY..DC.SDS  AI.K.LL.HI  VSPRCE.QAG  .-NK.G...Y 
 
            151 
HIV-2 Ali   LALVVVQQNG  KPQRNSTTRK  QWRRDYRRGL  RVARQDSRGL  KQRGGESPAP  
HIV-1 HxB2  ...AALITPK  .IKPPLPSVT  KLTE.RWNKP  QKTKGHRGSH  TMN.H* 
 
            201 
HIV-2 Ali   GAHFPGVAKV  LDILA* 
 
 Aminoacids in red - conserved motives present in all lentiviruses                               Ribeiro et al 2005 (4) 
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c-myc-H3.3 merge 
 HeLa cells 
1. Two-hybrid system mapping domains of Vif/H3.3 interaction 2. Cellular localization of HA-Vif1, HA-Vif2 and cmyc-H3.3 in HeLa transfected cells 
4. Homology sequence analysis between conserved amino acid residues from Vif1 and Vif2 proteins and Histone chaperons 
3. GST pull-down assay to study Vif/Histone H3.3 interaction 
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Conserved Vif motives, namely the sequence that 
encodes the amino acid residues – SLQYLA, present 
in all lentiviruses and other conserved motifs 
SLVKHHMYVSGKARGWFY (Vif1) and 
SLVKYLKRTKDLEKVCY (Vif2) have significant 
homology with ASF1 from several eukaryotic 
organisms. 
 
Homology sequence analysis was performed using 
BLAST and COBALT program to align multiple 
protein sequences. 
On panel A was shown GST-Vif/H3.3 interaction  with Vif  from HIV1, 
as well as, on panel D but in this case the interaction was between Vif 
from HIV2.  
 
Vif/H4 and H2A interactions were used as negative control (panel B, C, 
E and F). 
 
GST-Vif (1 and 2) unpurified proteins were incubated with 6 µg of each 
histone. Proteins were analyzed by Western blot with anti-GST and 
anti-histone antibodies. 
 
GST pull-down assays have confirm in vitro Vif/H3.3 histone 
interaction. 
 
When we use H2A, H2B and H4 in the same assay, we obtain negative 
results, suggesting that those histone don’t interact with Vif proteins. 
Alignment of HIV-1 Vif and HIV-2 Vif protein 
